Skip to main content

Table 1 Breast cancer tissue microarray patient characteristics

From: Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs

 

Number (n = 209)

Percent

ER/PR status

 ER-positive

163

78.0

 ER-negative

40

19.1

 PR-positive

120

57.4

 PR-negative

83

39.7

 ER-positive and PR-positive

117

56.0

 ER-positive and PR-negative

46

22.0

 ER-negative and PR-negative

37

17.7

 Unknown

6

2.9

HER2 status

 HER2-positive

59

28.2

 HER2-negative

140

67.0

 Intermediate

1

0.5

 Unknown

9

4.3

Lymph node status

 LN-positive

75

35.9

 LN-negative

111

53.1

 Unknown

23

11.0

Grade

 1

34

16.3

 2

96

45.9

 3

66

31.6

 Unknown

13

6.2

Tumor type

 Invasive ductal carcinoma

168

80.4

 Invasive lobular carcinoma

21

10.0

 DCIS

2

1.0

 Other

14

6.7

 Unknown

4

1.9

Tumor volume

 <10 cm3

64

30.6

 ≥10, <20 cm3

48

23.0

 >20 cm3

68

32.5

 Unknown

29

13.9

  1. The number and percentage of patient breast tumors included in the TMA study, stratified by various common breast tumor features
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us